The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome

被引:39
作者
Baumeister, FAM
Auer, DP
Hörtnagel, K
Freisinger, P
Meitinger, T
机构
[1] Tech Univ Munich, Childrens Hosp, D-80804 Munich, Germany
[2] Max Planck Inst Psychiat, NMR Study Grp, D-80804 Munich, Germany
[3] GSF, Natl Res Ctr Environm & Hlth, Inst Human Genet, Neuherberg, Germany
[4] Tech Univ Munich, Inst Human Genet, D-80804 Munich, Germany
关键词
Hallervorden-Spatz syndrome; pantothenate kinase 2; eye-of-the-tiger sign;
D O I
10.1055/s-2005-865714
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pantothenate kinase-associated neurodegeneration (PKAN), formerly Hallervorden-Spatz syndrome, is a rare autosomal recessive disorder characterized by extrapyramidal dysfunction as demonstrated by dystonia, rigidity, and choreoathetosis. Iron deposition in conjunction with destruction of the globus pallidus gives rise to the characteristic eye-of-the-tiger sign in MRI. It has been postulated that pantothenate kinase 2 mutations underlying all cases of classic Hallervorden-Spatz syndrome are always associated with the eye-of-the-tiger sign. Here, we report a patient with classic Hallervorden-Spatz syndrome and a homozygous pantothenate kinase 2 mutation in whom the initially present eye-of-the-tiger sign vanished during the course of the disease. Thus, the alleged one-to-one correlation between the eye-of-the-tiger sign and the presence of pantothenate kinase 2 mutation does not hold true over the course of the disease in PKAN.
引用
收藏
页码:221 / 222
页数:2
相关论文
共 10 条
[1]  
BARDOSA ER, 1995, ARQ NEURO-PSIQUIAT, V53, P294
[2]   Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome [J].
Davie, CA ;
Barker, GJ ;
Machado, C ;
Miller, DH ;
Lees, AJ .
MOVEMENT DISORDERS, 1997, 12 (05) :767-771
[3]   The eye-of-the-tiger sign [J].
Guillerman, RP .
RADIOLOGY, 2000, 217 (03) :895-896
[4]   Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. [J].
Hayflick, SJ ;
Westaway, SK ;
Levinson, B ;
Zhou, B ;
Johnson, MA ;
Ching, KHL ;
Gitschier, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) :33-40
[5]   Infantile neuroaxonal dystrophy and pantothenate kinase-associated neurodegeneration -: Locus heterogeneity [J].
Hörtnagel, K ;
Nardocci, N ;
Zorzi, G ;
Garavaglia, B ;
Botz, E ;
Meitinger, T ;
Klopstock, T .
NEUROLOGY, 2004, 63 (05) :922-924
[6]   An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria [J].
Hörtnagel, K ;
Prokisch, H ;
Meitinger, T .
HUMAN MOLECULAR GENETICS, 2003, 12 (03) :321-327
[7]   Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration [J].
Johnson, MA ;
Kuo, YM ;
Westaway, SK ;
Parker, SM ;
Ching, KHL ;
Gitschier, J ;
Hayflick, SJ .
REDOX-ACTIVE METALS IN NEUROLOGICAL DISORDERS, 2004, 1012 :282-298
[8]  
Molinuevo JL, 1999, MOVEMENT DISORD, V14, P169, DOI 10.1002/1531-8257(199901)14:1<169::AID-MDS1033>3.0.CO
[9]  
2-#
[10]   Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration [J].
Thomas, M ;
Hayflick, SJ ;
Jankovic, J .
MOVEMENT DISORDERS, 2004, 19 (01) :36-42